Thromb Haemost 1979; 42(05): 1503-1507
DOI: 10.1055/s-0038-1657051
Original Article
Schattauer GmbH Stuttgart

Increased Plasma Fibrinogen and Platelet-Aggregates in Type II Hyperlipoproteinaemia

G D O Lowe
The University Departments of Medicine and Cardiology, Royal Infirmary, Glasgow, Great Britain
,
Maureen M Drummond
The University Departments of Medicine and Cardiology, Royal Infirmary, Glasgow, Great Britain
,
Jane L H C Third
The University Departments of Medicine and Cardiology, Royal Infirmary, Glasgow, Great Britain
,
W F Bremner
The University Departments of Medicine and Cardiology, Royal Infirmary, Glasgow, Great Britain
,
C D Forbes
The University Departments of Medicine and Cardiology, Royal Infirmary, Glasgow, Great Britain
,
C R M Prentice
The University Departments of Medicine and Cardiology, Royal Infirmary, Glasgow, Great Britain
,
T D V Lawrie
The University Departments of Medicine and Cardiology, Royal Infirmary, Glasgow, Great Britain
› Author Affiliations
Further Information

Publication History

Received 08 May 1979

Accepted 19 June 1979

Publication Date:
23 August 2018 (online)

Summary

Plasma fibrinogen and platelet-aggregates (method of Wu and Hoak) were measured in 21 patients with familial Type II hyperlipoproteinaemia and 21 matched control subjects. Patients with hyperlipoproteinaemia had increased levels of fibrinogen and platelet- aggregates (p<0.01). Young patients with hyperlipoproteinaemia had prematurely high fibrinogen levels, and the normal rise in fibrinogen during adult life was abolished. There were no statistically significant correlations within the patient group between fibrinogen, platelet-aggregates, and plasma lipids. High fibrinogen and platelet-aggregate levels may play a part in the development of the premature arterial disease associated with Type II hyperlipoproteinaemia, or may be markers of arterial injury.

 
  • References

  • 1 Bottiger LE, Carlson LA. 1973. The Stockholm prospective study. 2. New events of coronary heart disease in men in relation to findings at initial examination, 9-year follow-up. In: Waldenstrom J, Larsson T, Ljungstedt N. (eds.) Early Phases of Coronary Heart Disease. The Possibility of Prediction Nordiska Borkhandelns Forlag; Stockholm: p 158
  • 2 Carvalho AC A, Colman RW, Lees RS. 1974; a Platelet function in hyperbetalipo- proteinaemia. New England Journal of Medicine 290: 434
  • 3 Carvalho AC A, Colman RW, Lees RS. 1974; b Clofibrate reversal of platelet hypersensitivity in hyperbetalipoproteinaemia. Circulation 50: 570
  • 4 Clauss A. 1957; Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematologica 17: 237
  • 5 Cotton RC, Wade EG, Spiller GW. 1963; The effect of Atromid on plasma fibrinogen and heparin resistance. Journal of Atherosclerosis Research 3: 648
  • 6 Dormandy JA, Hoare E, Colley J, Arrowsmith DE, Dormandy TL. 1973; a Clinical, haemodynamic, rheological, and biochemical findings in 126 patients with intermittent claudication. British Medical Journal 4: 576
  • 7 Dormandy JA, Hoare E, Khattab AH, Arrowsmith DE, Dormandy TL. 1973; b Prognostic significance of rheological and biochemical findings in patients with intermittent claudication. British Medical Journal 4: 581
  • 8 Hampton JR, Mitchell JR A. 1974; Platelet electrophoresis: the present position. Thrombosis et Diathesis Haemorrhagica 31: 204
  • 9 Lees RS, Wilson DE. 1971; The treatment of hyperlipidaemia. New England Journal of Medicine 284: 186
  • 10 Lowe GD O, Reavey MM, Johnston RV, Forbes CD, Prentice CR M. 1979; Increased platelet aggregates in vascular and non-vascular illness: correlation with plasma fibrinogen and effect of ancrod. Thrombosis Research 14: 377
  • 11 McDonald L, Edgill M. 1957; Coagulability ofthebloodinischaemicheart-disease. Lancet 2: 457
  • 12 Maca RD, Fry GL, Hoak JC. 1972; New method for detecting and quantitating circulating platelet aggregates. Microvascular Research 4: 453
  • 13 Mann JI, Vessey MP, Thorogood M, Doll R. 1975; Myocardial infarction in young women with special reference to oral contraceptive practice. British Medical Journal 2: 241
  • 14 Meade TW, Brozovic M, Chakrabarti R, Howarth DJ, North WR S, Stirling Y. 1976; An epidemiological study of the haemostatic and other effects of oral contraceptives. British Journal of Haematology 34: 353
  • 15 Meade TW, North WR S. 1977; Population-based distributions of haemostatic variables. British Medical Bulletin 33: 283
  • 16 Merskey C, Wohl H. 1964; Changes in blood coagulation and fibrinolysis in rats fed atherogenic diets. Thrombosis et Diathesis Haemorrhagica 10: 295
  • 17 Murray RG, Tweddel A, Third JL H C, Hutton I, Hillis WS, Lorimer AR, Lawrie TD V. 1975; Relation between extent of coronary artery disease and severity of hyperlipo- proteinaemia. British Heart Journal 37: 1205
  • 18 O’brien JR, Heywood JB, Heady JA. 1966; The quantitation of platelet aggregation by four compounds: a study in relation to myocardial infarction. Thrombosis et Diathesis Haemorrhagica 16: 752
  • 19 Prazich JA, Rapaport SI, Samples JR, Engler R. 1977; Platelet aggregate ratios - standardization of technique and test results in patients with myocardial ischaemia and patients with cerebrovascular disease. Thrombosis and Haemostasis 38: 597
  • 20 Smith EB, Alexander KM, Massievi B. 1976; Insoluble “fibrin” in human aortic intima. Quantitative studies on the relationship between insoluble “fibrin”, soluble fibrinogen and low density lipoprotein Atherosclerosis 23: 19
  • 21 Wu KK, Hoak JC. 1974; A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet 2: 924
  • 22 Wu KK, Armstrong ML, Hoak JC, Megan MB. 1975; Platelet aggregates in hypercholesterolaemic rhesus monkeys. Thrombosis Research 7: 917